324 related articles for article (PubMed ID: 24886459)
41. Pseudomyxoma Peritonei: Presentation of Two Cases and Challenging Issues in the Literature.
Pantiora EV; Massaras D; Koutalas J; Melemeni A; Fragulidis GP
Cureus; 2018 Dec; 10(12):e3732. PubMed ID: 30800542
[TBL] [Abstract][Full Text] [Related]
42. A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei.
Gilbreath JJ; Semino-Mora C; Friedline CJ; Liu H; Bodi KL; McAvoy TJ; Francis J; Nieroda C; Sardi A; Dubois A; Lazinski DW; Camilli A; Testerman TL; Merrell DS
Orphanet J Rare Dis; 2013 Jul; 8():105. PubMed ID: 23844722
[TBL] [Abstract][Full Text] [Related]
43. The Role of Microorganisms in Appendiceal Pseudomyxoma Peritonei: A Review.
Khamzina Y; King MC; Nieroda C; Merrell DS; Sardi A; Gushchin V
Curr Oncol; 2022 May; 29(5):3576-3584. PubMed ID: 35621679
[TBL] [Abstract][Full Text] [Related]
44. A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process.
Carr NJ; Cecil TD; Mohamed F; Sobin LH; Sugarbaker PH; González-Moreno S; Taflampas P; Chapman S; Moran BJ;
Am J Surg Pathol; 2016 Jan; 40(1):14-26. PubMed ID: 26492181
[TBL] [Abstract][Full Text] [Related]
45. Pseudomyxoma cutis; a new entity.
Terada T
Int J Clin Exp Pathol; 2013; 6(6):1169-76. PubMed ID: 23696938
[TBL] [Abstract][Full Text] [Related]
46. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential.
Ronnett BM; Kurman RJ; Zahn CM; Shmookler BM; Jablonski KA; Kass ME; Sugarbaker PH
Hum Pathol; 1995 May; 26(5):509-24. PubMed ID: 7750935
[TBL] [Abstract][Full Text] [Related]
47. [Pseudomyxoma peritonei : a cause of ascites that should not be underestimated].
Sinatra T; Coimbra Marques C
Rev Med Liege; 2018 Jul; 73(7-8):408-412. PubMed ID: 30113783
[TBL] [Abstract][Full Text] [Related]
48. Incidental Diagnosis of Pseudomyxoma Peritonei: A Case Report.
Sarpietro G; Iraci Sareri M; Bonanno GM; Matarazzo MG; Cianci A
Cureus; 2022 Mar; 14(3):e23425. PubMed ID: 35475088
[TBL] [Abstract][Full Text] [Related]
49. Pseudomyxoma peritonei--two novel orthotopic mouse models portray the PMCA-I histopathologic subtype.
Flatmark K; Reed W; Halvorsen T; Sørensen O; Wiig JN; Larsen SG; Fodstad Ø; Giercksky KE
BMC Cancer; 2007 Jun; 7():116. PubMed ID: 17603904
[TBL] [Abstract][Full Text] [Related]
50. Pathological prognostic factors of pseudomyxoma peritonei: comprehensive clinicopathological analysis of 155 cases.
Yan F; Lin Y; Zhou Q; Chang H; Li Y
Hum Pathol; 2020 Mar; 97():9-18. PubMed ID: 31926211
[TBL] [Abstract][Full Text] [Related]
51. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Baratti D; Kusamura S; Nonaka D; Cabras AD; Laterza B; Deraco M
Ann Surg; 2009 Feb; 249(2):243-9. PubMed ID: 19212177
[TBL] [Abstract][Full Text] [Related]
52. Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study.
Baratti D; Kusamura S; Milione M; Pietrantonio F; Caporale M; Guaglio M; Deraco M
Ann Surg Oncol; 2016 Dec; 23(13):4222-4230. PubMed ID: 27352203
[TBL] [Abstract][Full Text] [Related]
53. Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei).
Barrios P; Losa F; Gonzalez-Moreno S; Rojo A; Gómez-Portilla A; Bretcha-Boix P; Ramos I; Torres-Melero J; Salazar R; Benavides M; Massuti T; Aranda E
Clin Transl Oncol; 2016 May; 18(5):437-48. PubMed ID: 26489426
[TBL] [Abstract][Full Text] [Related]
54. Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome.
Pestieau SR; Esquivel J; Sugarbaker PH
Ann Surg Oncol; 2000 Apr; 7(3):199-203. PubMed ID: 10791850
[TBL] [Abstract][Full Text] [Related]
55. Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with Pseudomyxoma peritonei.
Deraco M; Gronchi A; Mazzaferro V; Inglese MG; Pennacchioli E; Kusamura S; Rizzi M; Anselmi RA; Vaglini M
Tumori; 2002; 88(5):370-5. PubMed ID: 12487553
[TBL] [Abstract][Full Text] [Related]
56. Management of an inguinal hernia in patients with pseudomyxoma peritonei.
Sugarbaker PH
Eur J Surg Oncol; 2017 Jun; 43(6):1083-1087. PubMed ID: 28131668
[TBL] [Abstract][Full Text] [Related]
57. Management of pseudomyxoma peritonei.
Fallis SA; Moran BJ
J BUON; 2015 May; 20 Suppl 1():S47-55. PubMed ID: 26051332
[TBL] [Abstract][Full Text] [Related]
58. Molecular genetic analysis of appendiceal mucinous adenomas in identical twins, including one with pseudomyxoma peritonei.
Shih IM; Yan H; Speyrer D; Shmookler BM; Sugarbaker PH; Ronnett BM
Am J Surg Pathol; 2001 Aug; 25(8):1095-9. PubMed ID: 11474297
[TBL] [Abstract][Full Text] [Related]
59. Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Baratti D; Kusamura S; Milione M; Bruno F; Guaglio M; Deraco M
Ann Surg Oncol; 2018 Feb; 25(2):404-413. PubMed ID: 29159742
[TBL] [Abstract][Full Text] [Related]
60. Pseudomyxoma peritonei accompanied by intraductal papillary mucinous neoplasm of the pancreas.
Mizuta Y; Akazawa Y; Shiozawa K; Ohara H; Ohba K; Ohnita K; Isomoto H; Takeshima F; Omagari K; Tanaka K; Yasutake T; Nakagoe T; Shirono K; Kohno S
Pancreatology; 2005; 5(4-5):470-4. PubMed ID: 15983445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]